Bottom line
IBBQ vs RYOIX: the short answer
IBBQ (Invesco Nasdaq Biotechnology ETF) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 58% by weight.
But IBBQ is far broader, holding 261 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.
IBBQ is cheaper at 0.19% vs 1.38% — a difference of $119 a year per $10,000 invested.
Over one year, RYOIX returned +30.7% vs −0.6% for IBBQ (reporting dates differ).
Updated Nov 19, 2026
IBBQ vs RYOIX side by side
| IBBQ | RYOIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Guggenheim |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.19% | 1.38% |
| Annual cost per $10k | $19 | $138 |
| 10-yr cost on $10k (prospectus) | $242 | $1,709 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | −0.6% | +30.7% |
| 5-yr return (annualized) | — | +4.0% |
| 10-yr return (annualized) | — | +5.9% |
| Best quarter | +12.0% | +28.3% |
| Worst quarter | −11.7% | −22.5% |
| Net assets (fund) | $67.4M | $136.8M |
| Number of holdings | 261 | 74 |
| Portfolio turnover | 17% | 75% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IBBQ | RYOIX | Difference |
|---|---|---|---|
| 2024 | −0.6% | −0.7% | +0.1% |
| 2023 | +4.5% | +6.1% | −1.6% |
| 2022 | −10.2% | −13.1% | +2.8% |
Source: Fund prospectus bar charts
Holdings overlap
17 of IBBQ's top 25 holdings also appear in RYOIX's top 25.
| Holding | IBBQ | RYOIX |
|---|---|---|
| Gilead Sciences, Inc. | 7.39% | 4.49% |
| Vertex Pharmaceuticals Inc. | 7.38% | 4.32% |
| Amgen Inc. | 7.10% | 5.05% |
| Regeneron Pharmaceuticals, Inc. | 5.08% | 2.93% |
| Alnylam Pharmaceuticals, Inc. | 3.19% | 2.36% |
| Revolution Medicines, Inc. | 2.48% | 2.48% |
| Biogen Inc. | 2.29% | 2.13% |
| Illumina, Inc. | 1.98% | 1.94% |
| United Therapeutics Corp. | 1.94% | 1.72% |
| argenx SE | 1.89% | 1.48% |
| Insmed Inc. | 1.83% | 1.79% |
| Incyte Corp. | 1.53% | 1.62% |
| Viatris Inc. | 1.49% | 1.55% |
| Moderna, Inc. | 1.48% | 2.15% |
| Guardant Health, Inc. | 1.35% | 1.72% |
Source: SEC Form N-PORT
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
RYOIX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FAQ
What is the difference between IBBQ and RYOIX?
Which is cheaper, IBBQ or RYOIX?
Should I own both IBBQ and RYOIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.